[
  {
    "ts": null,
    "headline": "GILD Announces Positive Data on Trodelvy in First-Line Breast Cancer",
    "summary": "Gileads Trodelvy shows significant improvement in PFS in phase III ASCENT-03 trial for first-line metastatic TNBC, reinforcing potential as backbone therapy.",
    "url": "https://finnhub.io/api/news?id=59e252a06081cb683c49cbd288138a67ba052f610771d7de42e9bb1e2d626fa1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748265360,
      "headline": "GILD Announces Positive Data on Trodelvy in First-Line Breast Cancer",
      "id": 134716316,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gileads Trodelvy shows significant improvement in PFS in phase III ASCENT-03 trial for first-line metastatic TNBC, reinforcing potential as backbone therapy.",
      "url": "https://finnhub.io/api/news?id=59e252a06081cb683c49cbd288138a67ba052f610771d7de42e9bb1e2d626fa1"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences' Best Days May Be Ahead - Here's Why",
    "summary": "Gilead Sciences' Best Days May Be Ahead - Here's Why",
    "url": "https://finnhub.io/api/news?id=4dc5c6c5ff94597181eb823c3d6e672dd445702ca8558a3b0817a52051744a8c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748255556,
      "headline": "Gilead Sciences' Best Days May Be Ahead - Here's Why",
      "id": 134700373,
      "image": "",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=4dc5c6c5ff94597181eb823c3d6e672dd445702ca8558a3b0817a52051744a8c"
    }
  },
  {
    "ts": null,
    "headline": "Gilead’s Phase III trial for breast cancer therapy meets primary goal",
    "summary": "The safety profile of the therapy in the trial was found to be consistent with previous trials.",
    "url": "https://finnhub.io/api/news?id=6026e8d56536f324903ec2ea9cb9c48d983c5cc306ac745a7fc46fdacb855188",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748249257,
      "headline": "Gilead’s Phase III trial for breast cancer therapy meets primary goal",
      "id": 134716318,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "The safety profile of the therapy in the trial was found to be consistent with previous trials.",
      "url": "https://finnhub.io/api/news?id=6026e8d56536f324903ec2ea9cb9c48d983c5cc306ac745a7fc46fdacb855188"
    }
  }
]